AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2012
Sep 6, 2012
30591_dirs_2012-09-06_573ff016-417f-42bd-abf6-efe27c90dcb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2012-09-04
Reporting Person: CROOKE STANLEY T (Director, Chairman, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-04 | Common Stock | M | 30000 | $5.25 | Acquired | 30000 | Direct |
| 2012-09-04 | Common Stock | S | 30000 | $14.1085 | Disposed | 0 | Direct |
| 2012-09-05 | Common Stock | M | 15000 | $5.25 | Acquired | 15000 | Direct |
| 2012-09-05 | Common Stock | S | 15000 | $14.823 | Disposed | 0 | Direct |
| 2012-09-06 | Common Stock | M | 8694 | $5.25 | Acquired | 8694 | Direct |
| 2012-09-06 | Common Stock | S | 8694 | $15.002 | Disposed | 0 | Direct |
| 2012-09-06 | Common Stock | M | 8694 | $5.25 | Acquired | 8694 | Direct |
| 2012-09-06 | Common Stock | S | 8694 | $15.035 | Disposed | 0 | Direct |
| 2012-09-06 | Common Stock | M | 1925 | $6.84 | Acquired | 1925 | Indirect |
| 2012-09-06 | Common Stock | S | 1925 | $15.035 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 4381 | $5.25 | Acquired | 4381 | Indirect |
| 2012-09-06 | Common Stock | S | 4381 | $15.035 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 306 | $5.25 | Acquired | 306 | Indirect |
| 2012-09-06 | Common Stock | S | 306 | $15.002 | Disposed | 0 | Indirect |
| 2012-09-06 | Common Stock | M | 6000 | $5.25 | Acquired | 6000 | Indirect |
| 2012-09-06 | Common Stock | S | 6000 | $15.002 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-04 | Employee Stock Option (right to buy) | $5.25 | M | 30000 | Disposed | 2013-01-02 | Common Stock (30000) | Direct |
| 2012-09-05 | Employee Stock Option (right to buy) | $5.25 | M | 15000 | Disposed | 2013-01-02 | Common Stock (15000) | Direct |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 17388 | Disposed | 2013-01-02 | Common Stock (17388) | Direct |
| 2012-09-06 | Employee Stock Option (right to buy) | $6.84 | M | 1925 | Disposed | 2013-01-01 | Common Stock (1925) | Indirect |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 4687 | Disposed | 2013-05-06 | Common Stock (4687) | Indirect |
| 2012-09-06 | Employee Stock Option (right to buy) | $5.25 | M | 6000 | Disposed | 2013-01-02 | Common Stock (6000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 875391 | Indirect |
Footnotes
F1: Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 6/27/2012.
F2: Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 6/27/2012.
More from IONIS PHARMACEUTICALS INC
Board/Management Information
2026
Jun 8
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27